Opinion/decision on a Paediatric investigation plan (PIP): Livtencity, Maribavir, decision type: PM: decision on the application ...
P/0183/2023 : EMA decision of 19 May 2023 on the acceptance of a modification of an agreed paediatric investigation plan for maribavir (Livtencity), (EMEA-000353-PIP02-16-M03) AdoptedReference Number: EMA/170667/2023